Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase EARLY_PHASE1 3Phase 1/2 3Phase 1 3Phase 4 1Phase 3 1

Status

Recruiting 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Breast Neoplasms 161Neoplasms 95Prostatic Neoplasms 86Glioblastoma 76Multiple Myeloma 66Pancreatic Neoplasms 64Glioma 62Brain Neoplasms 56Lung Neoplasms 46Carcinoma, Hepatocellular 45Melanoma 44Head and Neck Neoplasms 43Recurrence 42Carcinoma, Non-Small-Cell Lung 41Leukemia, Myeloid, Acute 40Colorectal Neoplasms 39Squamous Cell Carcinoma of Head and Neck 35Ovarian Neoplasms 35Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Neoplasm Metastasis 29Lymphoma, Non-Hodgkin 29Lymphoma 29Carcinoma, Renal Cell 28Polycystic Ovary Syndrome 27Stomach Neoplasms 24Hematologic Neoplasms 23Sarcoma 22Lymphoma, B-Cell 22Endometrial Neoplasms 20Uterine Cervical Neoplasms 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × OTHER × Advanced Pancreatic Cancer × Clear all
NCT07416240 2026-02-18

Exploratory Clinical Study of Claudin18.2-Targeted Activated DC and CAR-T Therapy in Advanced Pancreatic Cancer.

Hainan Cancer Hospital

Phase EARLY_PHASE1 Recruiting
10 enrolled
Gastrointestinal

Advanced Pancreatic Cancer

NCT05916261 2023-10-26

Personalized Tumor Vaccines and Pabolizumab in Patients With Advanced Pancreatic Cancer

Ruijin Hospital

Phase EARLY_PHASE1 Recruiting
54 enrolled
Gastrointestinal

Advanced Pancreatic Cancer

NCT05438797 2022-06-30

The Safety and Efficacy of Specific TIL-TCM Cells for Advanced Relapse-refractory or Metastatic Pancreatic Cancer

Jinling Hospital, China

Phase EARLY_PHASE1 Unknown
3 enrolled
Gastrointestinal

Advanced Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡